Role of NEDD8 in HIV-associated lipodystrophy

Differentiation

Volumn 77, Issue 2, 2009, Pages 148-153

  Esposito, Vincenzo ^a   Manente, Lucrezia ^b   Perna, Angelica ^b   Gargiulo, Miriam ^a   Viglietti, Rosaria ^a   Sangiovanni, Vincenzo ^a   Doula, Nectaria ^a   Liuzzi, Giuseppina ^c   Baldi, Alfonso ^b   De Luca, Antonio ^b   Chirianni, Antonio ^a  

^a AO Dei Colli Hospital for Infectious Diseases D Cotugno   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

Author keywords

HAART; HIV infection; Lipodystrophy; NEDD8

Indexed keywords

AMPRENAVIR; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; BETA CATENIN; COMPLEMENTARY DNA; EFAVIRENZ; GENOMIC DNA; INDINAVIR; MITOCHONDRIAL DNA; NEDD8 PROTEIN; PROTEIN P27; PROTEINASE INHIBITOR; RNA; SAQUINAVIR; STAVUDINE;

ADIPOGENESIS; ADIPOSE TISSUE; ANIMAL CELL; ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DISEASE COURSE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOBLOTTING; LIPODYSTROPHY; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN DEGRADATION; REAL TIME POLYMERASE CHAIN REACTION;

ADIPOCYTES; ANTI-HIV AGENTS; CELL CYCLE; CELL DIFFERENTIATION; HIV-1; HIV-ASSOCIATED LIPODYSTROPHY SYNDROME; HUMANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UBIQUITINS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 60549113897     PISSN: 03014681     EISSN: 14320436     Source Type: Journal    
DOI: 10.1016/j.diff.2008.09.016     Document Type: Article

References (22)

1. Barbaro G. Highly active antiretroviral therapy-associated metabolic syndrome: pathogenesis and cardiovascular risk. Am. J. Ther. 13 (2006) 248-260
2. Barragan P., Fisac C., and Podzamczer D. Switching strategies to improve lipid profile and morphologic changes. AIDS Rev. 8 (2006) 191-203
3. Bastard J.P., Caron M., Vidal H., Jan V., Auclair M., Vigouroux C., Luboinski J., Laville M., Maachi M., Girard P.M., Rozenbaum W., Levan P., and Capeau J. Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance. Lancet 359 (2002) 1026-1031
4. Boyd M., and Reiss P. The long-term consequences of antiretroviral therapy: a review. J. HIV Ther. 11 (2006) 26-35
5. Crosetto N., Bienko M., and Dikic I. Ubiquitin hubs in oncogenic networks. Mol. Cancer Res. 4 (2006) 899-904
6. Esposito V., Baldi A., De Luca A., Esposito V., Baldi A., De Luca A., Groger A.M., Loda M., Giordano G.G., Caputi M., Baldi F., Pagano M., and Giordano A. Prognostic role of the cyclin-dependent kinase inhibitor p27 in non small cell lung cancer. Cancer Res. 57 (1997) 3381-3385
7. Galli M., Polo R., Saint-Marc T., Walli R., and for the ART-Associated Lipodystrophy European Collaborative Study (ALECS) Group. Proposal for a clinic classification of morphological and metabolic alterations under ART. Antiviral Ther. 5 S5 (2000) 57
8. Giralt M., Domingo P., Guallar J.P., Rodriguez de la Concepción M.L., Alegre M., Domingo J.C., and Villarroya F. HIV-1 infection alters gene expression in adipose tissue, which contributes to HIV-1/HAART-associated lipodystrophy. Antiviral Ther. 11 (2006) 729-740
9. Gougeon M.L., Pénicaud L., Fromenty B., Leclercq P., Viard J.P., and Capeau J. Adipocytes targets and actors in the pathogenesis of HIV-associated lipodistrophy and metabolic alterations. Antiviral Ther. 9 (2004) 161-177
10. Gregoire F.M., Smas C.M., and Sul H.S. Understanding adipocyte differentiation. Physiol. Rev. 78 (1998) 783-809
11. Haubrich, R., Riddler, S., DiRienzo, D., 2007. Metabolic outcomes of ACTG 5142: a prospective, randomized, phase III clinical trial of NRTI-, PI and NNRTI-sparing regimens for initial treatment of HIV-1 infection. In: Program and Abstracts of the 14th Conference on Retroviruses and Opportunistic Infections, February 25-28, 2007, Los Angeles, CA (abstract 38).
12. Kravcik S. Update on HIV lipodystrophy. HIV Clin. Trials 5 (2004) 152-167
13. Mallon P.D. Pathogenesis of lipodystrophy and lipid abnormalities in patients taking antiretroviral therapy. AIDS Rev. 9 (2007) 3-15
14. Mokrzycki M.H., Harris C., May H., Laut S., and Palmisano J. Lactic acidosis associated with stavudine administration: a report of five cases. Clin. Infect. Dis. 30 (2000) 198-200
15. Moldes M., Zuo Y., Morrison R.F., Silva D., Park B.H., Liu J., and Farmer S.R. Perixosome-proliferator-activated receptor γ suppresses Wnt/β-catenin signalling during adipogenesis. Biochem. J. 376 (2003) 607-613
16. Pacenti M., Barzon L., and Favaretto F. Microarray analysis during adipogenesis identifies new genes altered by antiretroviral drugs. AIDS 20 (2006) 1691-1705
17. Pan Z.Q., Kentsis A., Dias D.C., Yamoah K., and Wu K. Nedd8 on cullin: building an expressway to protein destruction. Oncogene 23 (2004) 1985-1997
18. Podust V.N., Brownell J.E., Gladysheva T.B., Luo R.S., Wang C., Coggins M.B., Pierce J.W., Lightcap E.S., and Chau V. A Nedd8 conjugation pathway is essential for proteolytic targeting of p27 by ubiquitination. Proc. Natl. Acad. Sci. USA 97 (2000) 4579-4584
19. Reichert M., and Eick D. Analysis of cell cycle arrest in adipocyte differentiation. Oncogene 18 (1999) 459-466
20. Shibuyama S., Gevorkyan A., Yoo U., Tim S., Dzhangiryan K., and Scott J.D. Understanding and avoiding antiretroviral adverse events. Curr. Pharm. Des. 12 (2006) 1075-1090
21. Tateishi K., Omata M., Tanaka K., and Chiba T. The NEDD8 system is essential for cell cycle progression and morphogenetic pathway in mice. J. Cell Biol. 155 (2001) 571-579
22. Tien P.C., and Grunfeld C. What is HIV-associated lipodystrophy? Defining fat distribution changes in HIV infection. Curr. Opin. Infect. Dis. 17 (2004) 27-32